Losy J, Bernat R
Laboratory of Nervous System and Sensory Organs, Department of Physiology, School of Medicine, Poznań.
Acta Physiol Pol. 1989 Sep-Dec;40(5-6):479-85.
The purpose of the study was to investigate the relation between the catecholamines: noradrenaline and dopamine in the rat brain on one hand and hypoglycemic convulsions and coma on the other. Concentrations of noradrenaline in the hypothalamus, brain stem and cerebral cortex were decreased during hypoglycemic convulsions and were lower during coma than those during convulsions. Dopamine concentration in the striatum was decreased during convulsions and coma. It was shown that the decrease in concentration of catecholamines was a result of hypoglycemia but not of insulin action itself. Clonidine- alpha 2 agonist accelerated occurrence and prolonged duration of hypoglycemic convulsions. Haloperidol-dopamine receptor blocker had no effect on the time of occurrence or duration of convulsions and coma. The results indicate that noradrenaline may exert an inhibitory influence on hypoglycemic convulsions. No evidence has been provided to support involvement of dopamine in the control of hypoglycemic convulsions and coma.
该研究的目的是一方面调查大鼠脑中儿茶酚胺(去甲肾上腺素和多巴胺)之间的关系,另一方面调查其与低血糖惊厥和昏迷之间的关系。在低血糖惊厥期间,下丘脑、脑干和大脑皮层中的去甲肾上腺素浓度降低,且在昏迷期间低于惊厥期间。在惊厥和昏迷期间,纹状体中的多巴胺浓度降低。结果表明,儿茶酚胺浓度的降低是低血糖的结果,而非胰岛素作用本身的结果。可乐定-α2激动剂加速了低血糖惊厥的发生并延长了其持续时间。氟哌啶醇-多巴胺受体阻滞剂对惊厥和昏迷的发生时间或持续时间没有影响。结果表明,去甲肾上腺素可能对低血糖惊厥产生抑制作用。尚无证据支持多巴胺参与低血糖惊厥和昏迷的控制。